Wealth Dimensions Group, Ltd. Bristol Myers Squibb CO Transaction History
Wealth Dimensions Group, Ltd.
- $394 Million
- Q3 2024
A detailed history of Wealth Dimensions Group, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Dimensions Group, Ltd. holds 9,090 shares of BMY stock, worth $519,402. This represents 0.12% of its overall portfolio holdings.
Number of Shares
9,090
Previous 9,379
3.08%
Holding current value
$519,402
Previous $389,000
20.82%
% of portfolio
0.12%
Previous 0.11%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,535Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.07 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.31 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.45 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.49 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...